Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis

• US 5,741,645 A
• Filed: 06/06/1995
• Issued: 04/21/1998
• Est. Priority Date: 06/29/1993
• Status: Expired due to Term

• Current Assignee: Regents of The University of Minnesota (University of Minnesota)
• Original Assignee: Regents of The University of Minnesota (University of Minnesota)
• Inventors: Orr, Harry T., Chung, Ming-Yi, Ranum, Laura P. W., Zoghbi, Huda Y.
• Primary Examiner(s): Myers, Carla J.
• Application Number:
  US08/469,802
• Time in Patent Office: 1,050 Days
• Field of Search: 435/6, 435/912, 536/23.1, 536/23.5, 536/24.31, 536/24.33, 935/4, 935/6, 935/8, 935/9, 935/78, 935/11
• US Class Current: 435/6.13
• CPC Class Codes: C07K 14/47 from mammals
• CPC Class Codes: C07K 16/18 against material from animals or humans
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers
• CPC Class Codes: C12Q 2600/172 Haplotypes
• CPC Class Codes: G01N 2800/2835 Movement disorders, e.g. Parkinson, Huntington, Tourette
• CPC Class Codes: G01N 33/6896 Neurological disorders, e.g. Alzheimer's disease

Abstract

The present invention provides an isolated DNA sequence of the short arm of chromosome 6 which is located within the autosomal dominant spinocerebellar ataxia type 1 gene. This isolated DNA sequence is preferably located within a 3.36 kb EcoRI fragment, i.e., an EcoRI fragment containing about 3360 base pairs, of the SCA1 gene. The isolated sequence preferably contains a CAG repeat region. The number of CAG trinucleotide repeats (n) is≦36, preferably n=19-36, for normal individuals. For an affected individual n>36, preferably n≧43.

Claims

1. A method for identifying individuals at risk for developing spinocerebellar ataxia type 1 comprising the step of:

analyzing the CAG repeat region of a spinocerebellar ataxia type 1 gene wherein individuals at risk for developing spinocerebellar ataxia type 1 have greater than or equal to 43 CAG repeats.

2. The method of claim 1 wherein the analyzing step further comprises the steps of:

digesting genomic DNA with at least one restriction endonuclease to obtain DNA fragments;

separating the DNA fragments on a gel;

probing the DNA fragments with a probe capable of binding to the CAG repeat region;

detecting probe binding to the CAG repeat region.

3. The method of claim 2 comprising the additional step of:

sequencing the CAG repeat region.

4. The method of claim 1 wherein the analyzing step comprises the steps of:

performing a polymerase chain reaction with oligonucleotide primers capable of amplifying the CAG repeat region located within the spinocerebellar ataxia type 1 gene; and

detecting amplified DNA fragments containing the CAG repeat region.

5. A DNA fragment produced by the method of claim 4 wherein the DNA fragment contains a CAG repeat region and wherein the DNA fragment specifically hybridizes to a spinocerebellar ataxia type 1 gene.

6. The method of claim 4 comprising the additional step of sequencing the amplified DNA fragments.

7. The method of claim 4 wherein the oligonucleotide primers are selected from the group consisting of CCGGAGCCCTGCTGAGGT (SEQ ID NO:

8), CCAGACGCCGGGACAC (SEQ ID NO;

9), AACTGGAAATGTGGACGTAC (SEQ ID NO;

10), CAACATGGGCAGTCTGAG (SEQ ID NO;

11), CCACCACTCCATCCCAGC (SEQ ID NO;

12), TGCTGGGCTGGTGGGGGG (SEQ ID NO;

13), CTCTCGGCTTTCTTGGTG (SEQ ID NO;

14), and GTACGTCCACATTTCCAGTT (SEQ ID NO;

15).

8. The method of claim 1 wherein an individual not at risk for developing spinocerebellar ataxia type 1 has less than or equal to 36 CAG repeats.

9. An isolated DNA fragment having a sequence comprising bases 1716-1749 of SEQ ID NO:

1 of a spinocerebellar ataxia type 1 gene and a CAG repeat region.

10. The isolated DNA fragment of claim 9, wherein the CAG repeat region is optionally interrupted with CAG trinucleotides.

11. The isolated DNA fragment of claim 9, wherein there are at least 43 CAG repeats in the CAG repeat region.

12. The isolated DNA fragment of claim 10, wherein there are less than or equal to 36 CAG repeats in the CAG repeat region.

13. Isolated oligonucleotide primers selected from the group consisting of CCGGAGCCCTGCTGAGGT (SEQ ID NO:

8), CCAGACGCCGGGACAC (SEQ ID NO;

9), AACTGGAAATGTGGACGTAC (SEQ ID NO;

10), CAACATGGGCAGTCTGAG (SEQ ID NO;

11), CCACCACTCCATCCCAGC (SEQ ID NO;

12), TGCTGGGCTGGTGGGGGG (SEQ ID NO;

13), CTCTGGCTTTCTTGGTG (SEQ ID NO;

14), and GTACGTCCACATTTCCAGTT (SEQ ID NO;

15) useful for detecting spinocerebellar ataxia type 1.